Matches in SemOpenAlex for { <https://semopenalex.org/work/W2893214725> ?p ?o ?g. }
- W2893214725 abstract "The present study was designed to determine whether glycogen synthase kinase-3β (GSK-3β) was involved in the cardioprotection by α7 nicotinic acetylcholine receptor (α7nAChR) agonist and limb remote ischemic postconditionings. Forty male Sprague-Dawley rats were randomly divided equally into control (C), α7nAChR agonist postconditioning (P), limb remote ischemic postconditioning (L), combined α7nAChR agonist and limb remote ischemic postconditioning (P+L) groups. At the end of experiment, serum cTnI, creatine kinase-MB (CK-MB), tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), high mobility group protein (HMGB1) and interleukin-10 (IL-10) levels were measured; infarct size (IS), myocardial expressions of GSK-3β, p-GSK-3β (Ser9), nuclear factor-κB (NF-κB) and p-NF-κB (Ser536) in the ischemic area were assessed. The results showed that compared with group C, IS, serum cTnI and CK-MB levels obviously decreased in groups P, L and P+L. Compared with groups P and L, IS, serum cTnI and CK-MB levels significantly decreased in group P+L. Compared with group C, serum TNF-α, IL-6 and HMGB1 levels, and myocardial expression of p-NF-κBp65 (Ser536) evidently decreased, and myocardial expression of p-GSK-3β (Ser9) obviously increased in groups P, L and P+L. Compared with group P, serum TNF-α, IL-6 and HMGB1 levels and myocardial expression of p-NF-κBp65 (Ser536) significantly increased, and myocardial expression of p-GSK-3β (Ser9) evidently decreased in group L. Compared with group L, serum TNF-α, IL-6, HMGB1 levels, and myocardial expression of p-NF-κBp65 (Ser536) significantly decreased, and myocardial expression of p-GSK-3β (Ser9) obviously increased in group P+L. In conclusion, our findings indicate that inhibition of GSK-3β to decrease NF-κB transcription is one of cardioprotective mechanisms of α7nAChR agonist and limb remote ischemic postconditionings by anti-inflammation, but improved cardioprotection by combined two interventions is not completely attributable to an enhanced anti-inflammatory mechanism." @default.
- W2893214725 created "2018-10-05" @default.
- W2893214725 creator A5001436305 @default.
- W2893214725 creator A5016815290 @default.
- W2893214725 creator A5019135276 @default.
- W2893214725 creator A5073787546 @default.
- W2893214725 creator A5081492088 @default.
- W2893214725 creator A5086105416 @default.
- W2893214725 creator A5086275770 @default.
- W2893214725 date "2018-10-17" @default.
- W2893214725 modified "2023-10-14" @default.
- W2893214725 title "Inhibition of glycogen synthase kinase-3β is involved in cardioprotection by α7nAChR agonist and limb remote ischemic postconditionings" @default.
- W2893214725 cites W1847176359 @default.
- W2893214725 cites W1964906337 @default.
- W2893214725 cites W1965498805 @default.
- W2893214725 cites W1967612089 @default.
- W2893214725 cites W1978773293 @default.
- W2893214725 cites W1989352632 @default.
- W2893214725 cites W1998694879 @default.
- W2893214725 cites W2031672040 @default.
- W2893214725 cites W2035868461 @default.
- W2893214725 cites W2037825828 @default.
- W2893214725 cites W2038148672 @default.
- W2893214725 cites W2051110479 @default.
- W2893214725 cites W2054903524 @default.
- W2893214725 cites W2055410127 @default.
- W2893214725 cites W2064422427 @default.
- W2893214725 cites W2069368135 @default.
- W2893214725 cites W2076080662 @default.
- W2893214725 cites W2083308747 @default.
- W2893214725 cites W2087954426 @default.
- W2893214725 cites W2117037612 @default.
- W2893214725 cites W2120858735 @default.
- W2893214725 cites W2133523105 @default.
- W2893214725 cites W2145444845 @default.
- W2893214725 cites W2147553923 @default.
- W2893214725 cites W2165970906 @default.
- W2893214725 cites W2230341842 @default.
- W2893214725 cites W2285022406 @default.
- W2893214725 cites W2515667590 @default.
- W2893214725 cites W2564848902 @default.
- W2893214725 cites W2763956434 @default.
- W2893214725 cites W2796209661 @default.
- W2893214725 cites W2806052998 @default.
- W2893214725 cites W2809376706 @default.
- W2893214725 cites W2884413701 @default.
- W2893214725 doi "https://doi.org/10.1042/bsr20181315" @default.
- W2893214725 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6435451" @default.
- W2893214725 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30249754" @default.
- W2893214725 hasPublicationYear "2018" @default.
- W2893214725 type Work @default.
- W2893214725 sameAs 2893214725 @default.
- W2893214725 citedByCount "15" @default.
- W2893214725 countsByYear W28932147252019 @default.
- W2893214725 countsByYear W28932147252020 @default.
- W2893214725 countsByYear W28932147252021 @default.
- W2893214725 countsByYear W28932147252022 @default.
- W2893214725 countsByYear W28932147252023 @default.
- W2893214725 crossrefType "journal-article" @default.
- W2893214725 hasAuthorship W2893214725A5001436305 @default.
- W2893214725 hasAuthorship W2893214725A5016815290 @default.
- W2893214725 hasAuthorship W2893214725A5019135276 @default.
- W2893214725 hasAuthorship W2893214725A5073787546 @default.
- W2893214725 hasAuthorship W2893214725A5081492088 @default.
- W2893214725 hasAuthorship W2893214725A5086105416 @default.
- W2893214725 hasAuthorship W2893214725A5086275770 @default.
- W2893214725 hasBestOaLocation W28932147251 @default.
- W2893214725 hasConcept C115725540 @default.
- W2893214725 hasConcept C126322002 @default.
- W2893214725 hasConcept C134018914 @default.
- W2893214725 hasConcept C170493617 @default.
- W2893214725 hasConcept C17991360 @default.
- W2893214725 hasConcept C182996813 @default.
- W2893214725 hasConcept C184235292 @default.
- W2893214725 hasConcept C185592680 @default.
- W2893214725 hasConcept C192118531 @default.
- W2893214725 hasConcept C2777499176 @default.
- W2893214725 hasConcept C2778938600 @default.
- W2893214725 hasConcept C2779676291 @default.
- W2893214725 hasConcept C2780545709 @default.
- W2893214725 hasConcept C36880943 @default.
- W2893214725 hasConcept C500558357 @default.
- W2893214725 hasConcept C55493867 @default.
- W2893214725 hasConcept C71924100 @default.
- W2893214725 hasConceptScore W2893214725C115725540 @default.
- W2893214725 hasConceptScore W2893214725C126322002 @default.
- W2893214725 hasConceptScore W2893214725C134018914 @default.
- W2893214725 hasConceptScore W2893214725C170493617 @default.
- W2893214725 hasConceptScore W2893214725C17991360 @default.
- W2893214725 hasConceptScore W2893214725C182996813 @default.
- W2893214725 hasConceptScore W2893214725C184235292 @default.
- W2893214725 hasConceptScore W2893214725C185592680 @default.
- W2893214725 hasConceptScore W2893214725C192118531 @default.
- W2893214725 hasConceptScore W2893214725C2777499176 @default.
- W2893214725 hasConceptScore W2893214725C2778938600 @default.
- W2893214725 hasConceptScore W2893214725C2779676291 @default.
- W2893214725 hasConceptScore W2893214725C2780545709 @default.
- W2893214725 hasConceptScore W2893214725C36880943 @default.
- W2893214725 hasConceptScore W2893214725C500558357 @default.
- W2893214725 hasConceptScore W2893214725C55493867 @default.